Evidence mapPaperPMID 40483484Full record

ReviewLipids in health and disease2025

Correlation between dyslipidaemia and gastric cancer: pathogenesis to prevention and treatment strategies.

Tao Wu, Lingna Zhang, Jiao Tian, Yuyuan Lu, Yan Yang, Xin Yang, Penghui Jin, Yuanhui Gu, Xiaoke Wang, Lin Yi

Abstract readReview
In one paragraph

Review in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tao Wu *School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Lingna Zhang *School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Jiao TianSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Yuyuan LuSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Yan YangPharmacy Department, Gansu Provincial Hospital, Lanzhou, 730000, Gansu Province, China.
Xin YangFirst School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Penghui JinFirst School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China.
Yuanhui GuDepartment of General Surgery, Gansu Provincial Hospital, Lanzhou, 730000, Gansu Province, China.
Xiaoke WangDepartment of General Surgery, Gansu Provincial Hospital, Lanzhou, 730000, Gansu Province, China.
Lin YiSchool of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu Province, China. yxxxlyyy@163.com.

Funding

Gansu Provincial People's Hospital youth cultivation project No.20GSSY4-22Gansu Youth Science and Technology Fund program No.21JR7RA643Natural Science Foundation of Gansu Province No.24JRRA590Supported by the National Natural Science Foundation of China No.82160842
6 · The paper itself

Abstract

As the sixth most common cancer in the world, the development of gastric cancer (GC) is influenced by many factors. Recent studies have revealed a strong association between dyslipidaemia and GC. In this paper, the relationships between dyslipidaemia and GC are discussed in depth. We review the development of GC through the mechanisms of the inflammatory response, signalling pathways, and apolipoprotein function, and the intersecting targets of atherosclerosis and GC are explored. The synergistic effects of Helicobacter pylori infection and dyslipidaemia on the development of GC are also analysed, and the potential value of statins in the prevention and treatment of GC is discussed. In this review, we systematically investigated the relationship between dyslipidaemia and GC to provide new ideas for GC prevention and treatment.

Indexed as

DyslipidemiasHelicobacter InfectionsStomach NeoplasmsAtherosclerosisHelicobacter pyloriHumansHydroxymethylglutaryl-CoA Reductase InhibitorsSignal TransductionHydroxymethylglutaryl-CoA Reductase InhibitorsApolipoproteinsAtherosclerosisDyslipidaemiaGastric cancerStatins

Identifiers

PMID40483484
PMCPMC12144744

What Socratic holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.